---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-072930"
form_type: "8-K"
ticker: "TVRD"
cik: "0001346830"
company_name: "Tvardi Therapeutics, Inc."
filed_at: "2026-06-11T20:05:35+00:00"
generated_at: "2026-06-11T20:13:58.513400+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Tvardi stockholders elect directors, approve compensation, and ratify auditor

## Summary
- Imran Alibhai, Cynthia Smith, and Sujal Shah elected as Class II directors with 3.51M, 3.39M, 3.51M votes for; 2.98M broker non-votes.
- Non-binding advisory vote on executive compensation approved: 3.48M for, 0.16M against, 0.02M abstain.
- Stockholders chose 1-year frequency for future advisory votes on executive compensation (3.45M votes for 1 year).
- Ratification of Deloitte & Touche as independent auditor for FY2026 passed: 6.52M for, 0.06M against, 0.05M abstain.

## SEC filing metadata
- accession: 0001104659-26-072930
- form_type: 8-K
- ticker: TVRD
- cik: 0001346830
- company_name: Tvardi Therapeutics, Inc.
- filed_at: 2026-06-11T20:05:35+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1346830/000110465926072930/0001104659-26-072930-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1346830/000110465926072930/tm2617528d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-072930
- JSON: https://secwatch.observer/filing/0001104659-26-072930.json
- Plain text: https://secwatch.observer/filing/0001104659-26-072930.txt

## Key facts
- Shareholder Votes
  Tvardi Therapeutics, Inc. shareholders approved Non-Binding, Advisory Vote on Executive Compensation at the 2026-06-09 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-09
  source text: The stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers, by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 3,482,265 161,795 16,451 2,975,429
  evidence_url: https://www.sec.gov/Archives/edgar/data/1346830/000110465926072930/0001104659-26-072930-index.htm
- Shareholder Votes
  Tvardi Therapeutics, Inc. shareholders approved Election of Directors at the 2026-06-09 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-09
  source text: Imran Alibhai, Ph.D., Cynthia Smith and Sujal Shah were each elected to serve as a Class II director of the Company’s Board of Directors until the 2029 Annual Meeting of Stockholders
  evidence_url: https://www.sec.gov/Archives/edgar/data/1346830/000110465926072930/0001104659-26-072930-index.htm
- Shareholder Votes
  Tvardi Therapeutics, Inc. shareholders approved Advisory Vote on the Frequency of Solicitation of Advisory Stockholder Approval of Executive Compensation at the 2026-06-09 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2026-06-09
  source text: 3,513,039 147,472 Cynthia Smith 3,392,877 267,634 Sujal Shah 3,507,652 152,859 Broker Non-Votes: 2,975,429 Proposal 2 – Non-Binding, Advisory Vote on Executive Compensation The stockholders approved,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1346830/000110465926072930/0001104659-26-072930-index.htm
- Shareholder Votes
  Tvardi Therapeutics, Inc. shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2026-06-09 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-09
  source text: The stockholders ratified the selection by the Audit Committee of the Board of Directors of the Company of Deloitte & Touche LLP
  evidence_url: https://www.sec.gov/Archives/edgar/data/1346830/000110465926072930/0001104659-26-072930-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.